National Comprehensive Cancer Network

Educational Events & Programs

NCCN Guidelines Update Webinar Series™: Kidney Cancer

Register Now!

Program Overview

This 45-minute live webinar series will educate participants on issues considered by the NCCN Guidelines Panel resulting in the recent update to the NCCN Guidelines for Kidney Cancer. These issues include, but are not limited to, a comparison of new data with existing standards of care, involved patient subsets, and risk-benefit analysis in the diagnosis and treatment of the disease as well as a review of the significant studies that supported modification of the panels' recommendations.


Gary R. Hudes, MD
Fox Chase Cancer Center

Register now for one of the following sessions (each webinar provides the same content):

  • Friday, November 11, 2011 • 9:30 – 10:15 AM EST
  • Wednesday, November 16, 2011 • 10:30 – 11:15 AM EST
  • Wednesday, November 30, 2011 • 2:00 – 2:45 PM EST
  • Thursday, December 8, 2011 • 1:30 – 2:15 PM EST

Educational Objectives:

  • Describe recent advances in the management of patients with kidney cancer
  • Outline the implications of recent research and practice changes to the clinical algorithms for patients with kidney cancer

Intended Audience:

This educational program is designed to meet the educational needs of oncologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.


The National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education to physicians.

NCCN designates these live activities for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ each. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The National Comprehensive Cancer Network is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Each of these webinars is approved for 0.75 contact hour of continuing education for nurses.

Approval as a provider refers to recognition of educational activities only and does not imply ANCC Commission on Accreditation approval or endorsement of any product.

Kristina M. Gregory, RN, MSN, OCN, is our nurse planner for this educational activity.

Pharmacy Educational Objective
After completing these activities, the participant should be able to:

  • Provide accurate and appropriate counsel as part of the treatment team.

ACPE   National Comprehensive Cancer Network is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation:
National Comprehensive Cancer Network designates each of these continuing education activities for 0.75 contact hour(s) (0.075 CEUs) of continuing education credit in states that recognize ACPE accredited providers.

Type of Activity: Knowledge
Universal Activity Numbers: 0836-0000-11-028-L01-P

Fee Information:
There is no fee for this educational activity for registrants.

How to Claim Credit:
A statement of credit will be issued only upon receipt of a completed activity evaluation form/immediate post test and will be e-mailed to you immediately upon completion of the evaluation. To effectively issue certificates for this educational webinar, NCCN requires that every participant individually register for this activity, even if you plan to participate in this activity with a group of peers.

Faculty Disclosure:
All faculty participating in NCCN continuing education activities are expected to disclose any conflict(s) of interest related to the content of their presentation(s) as defined by the ACCME's, ACPE's,  and ANCC's Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME's Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.


This activity is supported by an educational grant from Pfizer.